Article
Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Jan 2022
Gibson Christopher J, Kim Haesook T, Zhao Lin, Murdock H Moses, Hambley Bryan, Ogata Alana, Madero-Marroquin Rafael, Wang Shiyu, Green Lisa, Fleharty Mark, Dougan Tyler, Cheng Chi-An, Blumenstiel Brendan, Cibulskis Carrie, Tsuji Junko, Duran Madeleine, Gocke Christopher D, Antin Joseph H, Nikiforow Sarah, DeZern Amy E, Chen Yi-Bin, Ho Vincent T, Jones Richard J, Lennon Niall J, Walt David R, Ritz Jerome, Soiffer Robert J, Gondek Lukasz P, Lindsley R Coleman
Abstract excerpt
PURPOSE: Clonal hematopoiesis (CH) can be transmitted from a donor to a recipient during allogeneic hematopoietic cell transplantation. Exclusion of candidate donors with CH is controversial since its impact on recipient outcomes and graft alloimmune function is uncertain. PATIENTS AND METHODS: We performed targeted error-corrected sequencing on samples from 1,727 donors age 40 years or older and assessed the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
